正文
《医学前沿(英文)》 >> 2019年 第13卷 第2期 doi: 10.1007/s11684-017-0599-3
Interferon-α salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation
. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.. Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100044, China
摘要
关键词
interferon-α ; hematopoietic stem cell transplantation ; minimal residual disease ; donor lymphocyte infusion
正文